Which medical history component is relevant to an In-111 Capromab Pendetide Scan?

The relevance of PSA (Prostate-Specific Antigen) levels in the context of an In-111 Capromab Pendetide scan is tied to the scan's use in evaluating prostate cancer. In-111 Capromab Pendetide is a radioimmunotherapy agent designed to target prostate-specific membrane antigen (PSMA), which is often elevated in patients with prostate cancer. By assessing the PSA levels in a patient's medical history, healthcare providers can determine the potential presence of prostate cancer and its aggressiveness, guiding the interpretation of the scan results.

Assessing other components, like blood glucose levels, liver function tests, or an electrolyte panel, while they may be relevant in different diagnostic contexts, do not provide critical information specific to the indication for the In-111 Capromab Pendetide scan. In summary, the PSA level is particularly pertinent in the evaluation of prostate cancer, making it the most relevant medical history component for this specific scan.